CorMedix (CRMD) Tops Q4 EPS by 5c

CorMedix (NASDAQ: CRMD) reported Q4 EPS of $0.22, $0.05 better than the analyst estimate of $0.17. Revenue for the quarter came in at $31.2 million versus the consensus estimate of $31 million.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
• Firefly Aerospace (FLY) call put ratio 2.9 calls to 1 put with a focus on September 28 calls as share price up 6.8%
• Iridium Communications (IRDM) July 50,55 and 60 calls active mid Rocket Lab (RKLB) acquiring